Annovis Bio, Inc. 07X.F Stock
Annovis Bio, Inc. Price Chart
Annovis Bio, Inc. 07X.F Financial and Trading Overview
| Annovis Bio, Inc. stock price | 7.93 EUR |
| Previous Close | 13.92 EUR |
| Open | 13.08 EUR |
| Bid | 13.18 EUR x N/A |
| Ask | 13.36 EUR x N/A |
| Day's Range | 13.08 - 13.08 EUR |
| 52 Week Range | 9.12 - 21.41 EUR |
| Volume | 300 EUR |
| Avg. Volume | 16 EUR |
| Market Cap | 117.79M EUR |
| Beta (5Y Monthly) | 1.208456 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.73 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 150 EUR |
07X.F Valuation Measures
| Enterprise Value | 108.59M EUR |
| Trailing P/E | N/A |
| Forward P/E | -5.089494 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.3365974 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Annovis Bio, Inc. Stock Price History
| Beta (5Y Monthly) | 1.208456 |
| 52-Week Change | 42.56% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.41 EUR |
| 52 Week Low | 9.12 EUR |
| 50-Day Moving Average | 13.29 EUR |
| 200-Day Moving Average | 13.45 EUR |
07X.F Share Statistics
| Avg. Volume (3 month) | 16 EUR |
| Avg. Daily Volume (10-Days) | 19 EUR |
| Shares Outstanding | 9.01M |
| Float | 6.34M |
| Short Ratio | N/A |
| % Held by Insiders | 30.74% |
| % Held by Institutions | 9.14% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -54.88% |
| Return on Equity (ttm) | -95.95% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -29831684 EUR |
| Diluted EPS (ttm) | -3.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.76M EUR |
| Total Cash Per Share (mrq) | 1.86 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.721 |
| Book Value Per Share (mrq) | 2.451 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25917458 EUR |
| Levered Free Cash Flow (ttm) | -15637975 EUR |
Profile of Annovis Bio, Inc.
| Country | Germany |
| State | PA |
| City | Berwyn |
| Address | 1055 Westlakes Drive |
| ZIP | 19312 |
| Phone | (610) 727-3913 |
| Website | https://www.annovisbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Q&A For Annovis Bio, Inc. Stock
What is a current 07X.F stock price?
Annovis Bio, Inc. 07X.F stock price today per share is 7.93 EUR.
How to purchase Annovis Bio, Inc. stock?
You can buy 07X.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Annovis Bio, Inc.?
The stock symbol or ticker of Annovis Bio, Inc. is 07X.F.
Which industry does the Annovis Bio, Inc. company belong to?
The Annovis Bio, Inc. industry is Biotechnology.
How many shares does Annovis Bio, Inc. have in circulation?
The max supply of Annovis Bio, Inc. shares is 11.94M.
What is Annovis Bio, Inc. Price to Earnings Ratio (PE Ratio)?
Annovis Bio, Inc. PE Ratio is now.
What was Annovis Bio, Inc. earnings per share over the trailing 12 months (TTM)?
Annovis Bio, Inc. EPS is -4.73 EUR over the trailing 12 months.
Which sector does the Annovis Bio, Inc. company belong to?
The Annovis Bio, Inc. sector is Healthcare.